New ARCHITECT plasma pro-gastrin-releasing peptide assay for diagnosing and monitoring small-cell lung cancer

@inproceedings{Nisman2016NewAP,
  title={New ARCHITECT plasma pro-gastrin-releasing peptide assay for diagnosing and monitoring small-cell lung cancer},
  author={Benjamin Nisman and Hovav Nechushtan and Haim Biran and Nir Peled and Hadas Gantz-Sorotsky and Victoria Doviner and Marina Perelman and Jair Bar and Amir Onn and Beatrice Uziely and Tamar Peretz},
  booktitle={British Journal of Cancer},
  year={2016}
}
Background:Progastrin-releasing peptide (ProGRP) is a potential marker for small-cell lung cancer (SCLC) in serum; however, it may be more stable in plasma. We investigated a new plasma assay (ProGRPp) and its usefulness in diagnosing and monitoring SCLC.Methods:The marker concentrations were determined on the ARCHITECT i system.Results:The assay could distinguish SCLC from non-small-cell lung cancer (NSCLC: area under the curve 0.931, 95% CI 0.893–0.969; cross-validated accuracy 0.813… CONTINUE READING
3 Citations
45 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 45 references

Enzyme - linked immunosorbent assay of pro - gastrin - releasing peptide for small cell lung cancer patients in comparison with neuron - specific enolase measurement

  • HJ Yang, Y Gu, C Chen, C Xu, YX Bao
  • Jpn J Cancer Res
  • 2011
Highly Influential
2 Excerpts

Similar Papers

Loading similar papers…